Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
126,442Documents
700Full text
2026-09-16Last indexed
Recent documents from this source
- NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma#349970
- Pembrolizumab, IRX-2, and Chemotherapy in Triple Negative Breast Cancer#349969
- Intralymphatic Immunotherapy for House Dust Mite, Dog, and Cat Allergy Using Tyrosine S® in Allergic Rhinitis#349968
- Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial#349967
- Predictive Role of Microbiome in Patients With Urothelial Carcinoma#349966
- Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-cell Lymphoma#349965
- Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96#349964
- Breast Phyllodes Tumors: Based on 20-year Real-world Data From China#349963
- Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer#349962
- Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer#349961
- Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients#349960
- Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer#349959
- Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer#349958
- D-CIK Combined With Chemotherapy for Non-Small Cell Lung Cancer(NSCLC)#349957
- Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma#349956
- SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx#349955
- Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm#349954
- Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma#349953
- BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma#349952
- Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas#349951
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).